Search Results - Thomas Forst

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Cover Image

    A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low‐dose liraglutide in otherwise healthy men with overweight... by Nadine Beetz, Brigitte Kalsch, Thomas Forst, Bernhard Schmid, Armin Schultz, Anita M. Hennige

    Published 2024
    Get full text
    Artículo Open Access

    Save to List
    Saved in:
  2. 2
    Cover Image

    Type 1 Diabetes and Other Autoimmune Diseases—Epidemiology, Pathophysiology and Screening by George J. Kahaly, Thomas Forst, Monika Kellerer, Stefanie Lanzinger, René D. Rötzer, Matthias Schott, Petra‐Maria Schumm‐Draeger

    Published 2025
    Get full text
    Artículo Open Access

    Save to List
    Saved in:
  3. 3
    Cover Image

    The role of incretin receptor agonists in the treatment of obesity by Thomas Forst, Christophe De Block, Stefano Del Prato, Sara Armani, Juan Frias, Anne Lautenbach, Bernhard Ludvik, Marina Marinez, Chantal Mathieu, Timo D. Müller, Oliver Schnell

    Published 2024
    Get full text
    Artículo Open Access

    Save to List
    Saved in:

Search Tools: